Page 44 - Webcast Information News Today

Message : Required fields Net income of $61.2 million, or $0.28 per diluted share, for the first quarter of 2021, compared to $50.1 million, or $0.23 per diluted share, for the fourth quarter of 2020. The net income for the first quarter of 2021 and fourth quarter of 2020 included the following items of note: - Provision for credit losses was a net benefit of $15.3 million ($9.5 million after-tax, or an increase of $0.04 per diluted share) for the first quarter of 2021, compared to an expense o...

Atlas Announces First Quarter 2021 Results Conference Call and Webcast News provided by Share this article Share this article LONDON, April 15, 2021 /PRNewswire/ - Atlas Corp. ("Atlas") (NYSE: ATCO) plans to release its financial results for the quarter ended March 31, 2021 after the market close on Monday, May 3, 2021. Atlas plans to host a conference call for all shareholders and interested parties at 8:30 a.m. Eastern Time (ET) on Tuesday, May 4, 2021 to discuss the results. Conference Call ...

Share this article Share this article RED BANK, N.J., April 8, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that the Company received a notification on April 2, 2021 from the U.S. Food and Drug Administration (FDA), stating that, as part of its ongoing review of the Companys Biologic License Application (BLA) for teplizumab for the delay or prevention of clinical type 1 di...

U.S. Conference Call Number: (844) 589-0917 International Conference Call Number: (647) 253-8649 Conference ID: 6551218 A conference call replay will be available after 7:00 p.m. Central time on April 22 through 11:59 p.m. Central time on April 29 at (800) 585-8367 (United States); (416) 621-4642 (International). The conference ID is 6551218. A webcast replay will also be accessible via the Knowles website at http://investor.knowles.com. About Knowles: Knowles Corporation (NYSE: KN) is a marke...

Cathay General Bancorp to Announce First Quarter 2021 Financial Results News provided by Share this article Share this article LOS ANGELES, April 8, 2021 /PRNewswire/ -- Cathay General Bancorp (Nasdaq: CATY), the holding company for Cathay Bank, is scheduled to announce its first quarter 2021 financial results after the markets close on Monday, April 26, 2021.  Cathay General Bancorp has scheduled a conference call as set forth below. Analysts and investors may participate in the question-and...

Share this article Share this article ALHAMBRA, Calif., March 10, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2020. Financial Highlights for the Fourth Quarter and Year Ended December 31, 2020: Company e...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Amarin Corporation plcFebruary 25, 2021 GMT Record Revenue of $614.1 Million and $167.3 Million for Full Year and Fourth Quarter 2020 Despite COVID-19 Impact Received Positive CHMP Opinion for VAZKEPA ® in Europe and Continue to Advance Commercial Launch Plans for Europe Management to Host Conference Call...

Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update -U.S. Food and Drug Administration (FDA) filing of a Biologics License Application (BLA) and Priority Review for teplizumab for the delay or prevention of clinical type 1 diabetes in at-risk individuals; PDUFA goal date of July 2, 2021- News provided by Share this article Share this article RED BANK, N.J., Feb. 25, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical ...

Jounce Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results – Commenced enrollment in both the Phase 1 INNATE trial of JTX-8064 (LILRB2 / ILT4) and the Phase 2 SELECT trial of Vopratelimab in combination with JTX-4014 – – Ended 2020 with $213.2 million in cash, cash equivalents and investments – – Company to host conference call and webcast today at 8:00 AM ET – CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clini...

Atlantic Power Corporation Announces Dates for Fourth Quarter and Year End 2020 Results and Conference Call News provided by Share this article Share this article DEDHAM, Mass., Feb. 22, 2021 /PRNewswire/ -- Atlantic Power Corporation (NYSE: AT) (TSX: ATP) ("Atlantic Power" or the "Company") plans to release its financial results for the three months and year ended December 31, 2020 after the market closes on the afternoon of Thursday, March 4, 2021. A telephone conference call and webcast hos...